stella
beta
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease — Stella
Recruiting
Back to Autoimmune Diseases trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
View full record on ClinicalTrials.gov